Francesco Fedele to Lipopolysaccharides
This is a "connection" page, showing publications Francesco Fedele has written about Lipopolysaccharides.
Connection Strength
0.053
-
Discovery of a novel 1,3,4-oxadiazol-2-one-based NLRP3 inhibitor as a pharmacological agent to mitigate cardiac and metabolic complications in an experimental model of diet-induced metaflammation. Eur J Med Chem. 2023 Sep 05; 257:115542.
Score: 0.053